Desogestrel/Ethinyl Estradiol Shortage Update: What Patients Need to Know in 2026

If you have recently struggled to fill a prescription for desogestrel/ethinyl estradiol -- sold as Apri, Kariva, Reclipsen, Mircette, and more than 20 other brand names -- you may be wondering if there is a shortage. Here is the most up-to-date information for 2026, along with practical guidance for what to do if your pharmacy is out of stock.

Is There an Official Desogestrel/Ethinyl Estradiol Shortage in 2026?

No. As of 2026, the FDA Drug Shortages Database does not list desogestrel/ethinyl estradiol as a medication in shortage. This drug is produced by multiple manufacturers under more than 25 brand names, including Apotex, Teva, Lupin, Mayne Pharma, and others. The broad generic manufacturing base makes a widespread national shortage unlikely compared to drugs with only one or two suppliers.

That said, the absence of a national shortage does not mean every pharmacy will have your specific brand in stock every time you need a refill. Local and regional availability gaps do occur, and they can feel just as frustrating as a formal shortage.

Why Are Some Patients Having Trouble Filling Their Prescription?

There are several reasons why patients may encounter stock gaps even when the drug is not in an official shortage:

Brand fragmentation: With 25+ brand names across four formulation types, each pharmacy only stocks a limited subset. If they do not carry your specific brand, they may not have an in-stock equivalent without special ordering.

Manufacturing production cycles: Generic manufacturers rotate production lines across many products. A manufacturer may produce a particular desogestrel/ethinyl estradiol brand in batches, and during gaps between production runs, wholesale inventory can temporarily drop.

Telehealth-driven demand increases: The rapid growth of online contraceptive services since 2020 has significantly increased prescriptions for oral contraceptives at the national level, putting more demand pressure on pharmacy inventory than in previous years.

Insurance formulary changes: Annual insurance plan changes, which take effect each January, can shift which brand is preferred on your plan. This can temporarily mismatch what your pharmacy stocks versus what your insurance covers.

Which Brands of Desogestrel/Ethinyl Estradiol Are Most Commonly Available?

The most widely stocked brands at national chain pharmacies tend to be the monophasic formulations, particularly Apri (Teva), Reclipsen (Warner Chilcott), and Enskyce (Lupin). These are the highest-volume generics and are routinely ordered by pharmacies with high prescription volume. Less commonly stocked brands may need to be special ordered, which can take 1-3 business days.

What Should Patients Do Right Now?

If you are having trouble filling your prescription, here are immediate steps to take:

Do not stop taking your pills abruptly without medical guidance. If you have any pills left, continue taking them as directed.

Call your pharmacy and ask if they can special order your brand or substitute an equivalent monophasic generic.

Use medfinder to search nearby pharmacies. medfinder calls pharmacies in your area to find who has your medication in stock and texts you results.

Contact your prescriber if you cannot locate any version of the medication. They can issue a new prescription for an equivalent alternative.

Use backup contraception (condoms) if you have missed two or more active pills or are making any mid-cycle switch.

39,049+ patients found their medications in stock

39K+

Find Desogestrel/Ethinyl Estradiol In Stock Today →

How to Stay Ahead of Stock Issues Going Forward

The best way to avoid running into stock issues is to refill early -- most insurance plans allow a refill when you have 7 days of pills remaining. You can also ask your prescriber to write for a 90-day supply and fill through a mail-order pharmacy, which significantly reduces the frequency of refill runs and the risk of encountering a local stock gap.

The Bottom Line on Availability in 2026

Desogestrel/ethinyl estradiol is not in a national FDA shortage in 2026. It is widely manufactured and generally available across the pharmacy system. Local stock gaps at specific locations are the primary problem patients face. medfinder helps bridge that gap by calling pharmacies for you and identifying where to fill your prescription today.

Related: Why is desogestrel/ethinyl estradiol hard to find? | Alternatives to desogestrel/ethinyl estradiol.